Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Medicines · US (FDA)
Diabetes medicines

FDA 2007

Sulfonylureas

Glyburide

Approved 18 Oct 2007OralTablet

The FDA lists this product in 30 strengths and forms.

Official labelAsk Osler about it

On this page

Composition
Strengths and forms
Official product information

The table holds no label text for this product yet, only the facts beside it. The official product information has the full text.

Composition

Active ingredients: GLYBURIDE 1.25MG

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

GLYBURIDE 1.25MG · TabletThis page
GLYBURIDE 2.5MG · TabletANDA077537-002 · Discontinued
GLYBURIDE 5MG · TabletANDA077537-003 · Discontinued
GLYBURIDE 5MG · TabletANDA076257-003 · Prescription
GLYBURIDE 1.25MG · TabletANDA076257-001 · Prescription
GLYBURIDE 2.5MG · TabletANDA076257-002 · Prescription
GLYBURIDE 5MG · TabletANDA203379-003 · Prescription
GLYBURIDE 1.25MG · TabletANDA203379-001 · Prescription
GLYBURIDE 2.5MG · TabletANDA203379-002 · Prescription
GLYBURIDE 2.5MG · TabletANDA090937-002 · Prescription
GLYBURIDE 5MG · TabletANDA090937-003 · Prescription
GLYBURIDE 1.25MG · TabletANDA090937-001 · Prescription
GLYBURIDE 5MG · Tablet

More in diabetes medicines

DapagliflozinTablet
Dapagliflozin and Metformin Hydrochloridedapagliflozin · Tablet, extended release

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

ANDA203581-003 · Discontinued

GLYBURIDE 1.25MG · TabletANDA203581-001 · Discontinued

GLYBURIDE 2.5MG · TabletANDA203581-002 · Discontinued

GLYBURIDE 2.5mg · TabletANDA206749-002 · Prescription

GLYBURIDE 5MG · TabletANDA206749-003 · Prescription

GLYBURIDE 1.25mg · TabletANDA206749-001 · Prescription

GLYBURIDE 2.5MG · TabletANDA074388-002 · Prescription

GLYBURIDE 5MG · TabletANDA074388-003 · Prescription

GLYBURIDE 1.25MG · TabletANDA074388-001 · Prescription

GLYBURIDE 6MG · TabletANDA075947-003 · Discontinued

GLYBURIDE 1.5MG · TabletANDA075947-001 · Discontinued

GLYBURIDE 3MG · TabletANDA075947-002 · Discontinued

GLYBURIDE 5MG · TabletANDA206483-003 · Prescription

GLYBURIDE 1.25MG · TabletANDA206483-001 · Prescription

GLYBURIDE 2.5MG · TabletANDA206483-002 · Prescription

GLYBURIDE 2.5MG · TabletANDA206079-002 · Prescription

GLYBURIDE 5MG · TabletANDA206079-003 · Prescription

GLYBURIDE 1.25MG · TabletANDA206079-001 · Prescription

Official product information

Drugs@FDA lists the approved labels, letters and reviews for application ANDA077537.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Glyburide
Drug class: Sulfonylureas
Group: Diabetes medicines
Route: Oral
Dosage form: Tablet
Applicant: Aurobindo Pharma
Status: Discontinued
FDA approval: 18 Oct 2007
Application: ANDA077537-001
RxCUI: 4815

Guidelines

Guidelines in endocrinology and metabolism950 guidelines in the library

FDA 2026Dapagliflozin and Saxagliptin Hydrochloridedapagliflozin · Tablet

FDA 2025Wegovysemaglutide · Tablet

FDA 2025Sitagliptin and Metformin Hydrochloridemetformin hydrochloride · Tablet

FDA 2025Kirstyinsulin aspart-xjhz · Injection

FDA 2024LiraglutideSolution

FDA 2024Sitagliptin and Metformin HCLsitagliptin, metformin hydrochloride · Tablet

FDA 2024Zituvimet XRmetformin hydrochloride · Tablet, extended release

FDA 2023Zepboundtirzepatide · Solution

FDA 2023Zepbound (Autoinjector)tirzepatide · Solution

FDA 2023Zepbound Kwikpentirzepatide · Solution

FDA 2023Zituvimetmetformin hydrochloride · Tablet

FDA 2023Zituviositagliptin · Tablet

FDA 2023Saxagliptin and Metformin Hydrochloridemetformin hydrochloride · Tablet, extended release

FDA 2023Saxagliptinsaxagliptin hydrochloride · Tablet

FDA 2023Inpefasotagliflozin · Tablet

FDA 2023Brenzavvybexagliflozin · Tablet